ArcTern invests in Terramera to boost sustainable farming practices
Category: #business  By Akshay Kedari  Date: 2020-01-29
  • share
  • Twitter
  • Facebook
  • LinkedIn

ArcTern invests in Terramera to boost sustainable farming practices

 

  • Terramera closed the funding round with USD 48.5 million with other investors including S2G ventures, Ospraie Ag Science
  • The investment marks ArcTern’s fourth financing from its USD 200 million value Fund II

 

Vancouver headquartered sustainable agriculture technology startup Terramera has reportedly raised investment from Canada’s prominent cleantech fund entity, ArcTern, in an extended Series B round. S2G Ventures and Ospraie Ag Science also participated in the round and the total funding raised was US$48.5 million.

For the record, the agriculture tech startup is developing novel technologies to change the way food is grown and disrupt the economics of agriculture. With the help of Actigate™ - a targeted performance technology, the company aims at constantly reducing the synthetic pesticide load across the globe by close to 80% by 2030.

Arc Tern aims at investing in innovative and advanced clean technology firms that address the problems associated with climate change and promote sustainability. The bio platform approach of ArcTern Ventures which combines science with data collection and nature supported its latest investment in Terramera.

The new approach carries the potential to positively affect the farming practices which not only help in enhanced farm operations in terms of water, use of pesticides and nutrients but also supplement the use of regenerative agricultural methods.

According to Tom Rand, Managing Partner at ArcTern, Terramera possesses the expertise and technology to change commercial agriculture in an organized manner. The approach adopted by the startup will lead to enhanced farm productivity and the ability to remove carbon from well-managed soils, he further added.

ArcTern Ventures is a leading venture capital company based in Toronto. The company constantly invests in innovative clean technologies that address depleting environmental issues and sustainability.

For the record, ArcTern was established by Tom Rand and Murray McCaig with the belief that the escalating shift towards a greener economy will disrupt all the industries and foster a successful business opportunity for both huge financial returns and positive impact on the environment. 
 

Source Credits: https://www.prnewswire.com/news-releases/arctern-ventures-announces-investment-in-agtech-leader-terramera-300992997.html
 

About Author

Akshay Kedari    

Akshay Kedari

Akshay holds a Bachelor’s degree in computer engineering. Despite having a penchant for software development and the like, Akshay took to writing as a career owing to his passion for the field. Presently, Akshay writes articles for itresearchbrief.com and a few oth...

Read More>>

More News By Akshay Kedari

Ascentage Pharma gets approval for Phase Ib/II trial of APG-1387
Ascentage Pharma gets approval for Phase Ib/II trial of APG-1387
By Akshay Kedari

Ascentage Pharma, a clinical-stage biotechnology firm developing innovative therapies for cancers, h...

VBL Therapeutics launches Phase 2 clinical trial for colorectal cancer
VBL Therapeutics launches Phase 2 clinical trial for colorectal cancer
By Akshay Kedari

VBL Therapeutics, a renowned Israeli biopharmaceutical company, reportedly announced the initiation ...

Matinas BioPharma to start Part 2 study of MAT2203 for HIV-patients
Matinas BioPharma to start Part 2 study of MAT2203 for HIV-patients
By Akshay Kedari

Matinas BioPharma, a renowned biopharmaceutical company, has reportedly announced that DSMB (Data Sa...